Natalie T Mills

9PUBLICATIONS
56CO-AUTHORS
Clinical psychologyClinical and health psychology not elsewhere classifiedPsychological methodology, design and analysisMolecular medicineEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 30, 2026
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial: commentary, author response.

|Jul 06, 2026
Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS study.

|Mar 31, 2026
Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study - RETRACTION.

Natalie T Mills, Stevan Nikolin, Nick Glozier

|Jan 07, 2025
Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study.

Natalie T Mills, Stevan Nikolin, Nick Glozier

|Mar 05, 2024
Emotional Blunting in Depression in the PREDDICT Clinical Trial: Inflammation-Stratified Augmentation of Vortioxetine With Celecoxib.

Emma Sampson, Erhan Kavakbasi, Natalie T Mills

|Aug 28, 2023
Inflammation-stratified augmentation of vortioxetine with celecoxib: Results from a double-blind, randomized, placebo-controlled trial in major depressive disorder.

Erhan Kavakbasi, Emma Sampson, Natalie T Mills

Pageof 2

Frequent Collaborators

4 joint publications

Mary Lou Chatterton

4 joint publications

Philip Bowden Mitchell

4 joint publications

Bernhard T Baune

4 joint publications

Colleen Loo